EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

A study of roflumilast treatment on functional and structural changes in hippocampus in depressed Adult male Wistar rats

Ghida Hassan iD, Sherif A Kamar iD, Hagar Yousry Rady, Dina Sayed Abdelrahim iD, Nesma Hussein Abdel Hay Ibrahim iD, Noha N Lasheen

PLOS ONE · 2024

DOI: 10.1371/journal.pone.0296187 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS ONE, 2024. Verfasst von Ghida Hassan und 5 weiteren Autor:innen. Beteiligte Einrichtung: Medical Physiology Department, Faculty of Medicine, Ain Shams University, Cairo, Egypt. Hauptthemen laut MEDLINE: Phosphodiesterase 4 Inhibitors, Neurodegenerative Diseases, Aminopyridines, Benzamides. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 63 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Depression is a common stress disability disorder that affects higher mental functions including emotion, cognition, and behavior. It may be mediated by inflammatory cytokines that interfere with neuroendocrine function, and synaptic plasticity. Therefore, reductions in inflammation might contribute to treatment response. The current study aims to evaluate the role of Protein Kinase (PKA)- cAMP response element-binding protein (CREB)- brain derived neurotropic factor (BDNF) signaling pathway in depression and the effects of roflumilast (PDE4 inhibitor) as potential antidepressant on the activity of the PKA-CREB-BDNF signaling pathway, histology, and pro-inflammatory cytokine production. Forty Adult male Wistar rats were divided into 4 groups: Control group, Positive Control group: similar to the controls but received Roflumilast (3 mg / kg / day) by oral gavage for the last 4 weeks of the experiment, Depressed group which were exposed to chronic stress for 6 weeks, and Roflumilast-treated group which were exposed to chronic stress for 6 weeks and treated by Roflumilast (3 mg / kg / day) by oral gavage for the last 4 weeks of the experiment. The depressed group showed significant increase in immobility time with significant decrease in swimming and struggling times, significant decrease in hippocampal PKA, CERB, BDNF, Dopamine, Cortisone, and Superoxide dismutase while hippocampal Phosphodiesterase-E4, Interleukin-6, and Malondialdhyde levels were significantly elevated. These findings were significantly reversed upon Roflumilast treatment. Therefore, it could be concluded that depression is a neurodegenerative inflammatory disease and oxidative stress plays a key role in depression. Roflumilast treatment attenuated the depression behavior in rats denoting its neuroprotective, and anti-inflammatory effects.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Phosphodiesterase 4 InhibitorsNeurodegenerative DiseasesAminopyridinesBenzamidesRatsMaleAnimalsRats, WistarBrain-Derived Neurotrophic FactorHippocampusCyclic AMP Response Element-Binding ProteinCyclopropanes

Substanzen

RoflumilastBrain-Derived Neurotrophic FactorPhosphodiesterase 4 InhibitorsCyclic AMP Response Element-Binding ProteinAminopyridinesBenzamidesCyclopropanes

Autor:innen und Institutionen

  • Medical Physiology Department, Faculty of Medicine, Ain Shams University, Cairo, Egypt.
  • Anatomy Department, Faculty of Medicine, Ain Shams University, Cairo, Egypt.
  • Faculty of Dentistry, Al-Ahliyya Amman University, Amman, Jordan.
  • Anatomy Department, Armed Forces College of Medicine, Cairo, Egypt.
  • Clinical Pharmacology department, Faculty of Medicine, Ain Shams University, Cairo, Egypt.
  • Pharmacology Department, Faculty of Medicine, Modern University for Technology and Information, Cairo, Egypt.

ORCID-Profile: Ghida Hassan, Sherif A Kamar, Dina Sayed Abdelrahim, Nesma Hussein Abdel Hay Ibrahim

Zitieren

APA

Hassan, G., Kamar, S. A., Rady, H. Y., Abdelrahim, D. S., Abdel Hay Ibrahim, N. H., & Lasheen, N. N. (2024). A study of roflumilast treatment on functional and structural changes in hippocampus in depressed Adult male Wistar rats. PLOS ONE. https://doi.org/10.1371/journal.pone.0296187

Vancouver

Hassan G, Kamar SA, Rady HY, Abdelrahim DS, Abdel Hay Ibrahim NH, Lasheen NN. A study of roflumilast treatment on functional and structural changes in hippocampus in depressed Adult male Wistar rats. PLOS ONE. 2024. doi:10.1371/journal.pone.0296187

BibTeX
@article{Hassan2024,
  author = {Hassan, Ghida and Kamar, Sherif A and Rady, Hagar Yousry and Abdelrahim, Dina Sayed and Abdel Hay Ibrahim, Nesma Hussein and Lasheen, Noha N},
  title = {A study of roflumilast treatment on functional and structural changes in hippocampus in depressed Adult male Wistar rats},
  journal = {PLOS ONE},
  year = {2024},
  doi = {10.1371/journal.pone.0296187}
}
Kostenlos starten →